T900607 in Treating Patients With Unresectable Liver Cancer

NCT00054262 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Liver Cancer

Interventions

DRUG: T900607

Sponsor

University Hospitals Seidman Cancer Center

Collaborators

[object Object]